To get a better understanding of the abnormal differentiation or maturation of keratinocytes, we studied the expression and distribution of cytokeratin and involucrin in lesions from systemic lupus erythematosus patients. Two groups of 10 specimens each from systemic lupus erythematosus and normal controls were analyzed by two-dimensional gel electrophoresis, mass spectrometric protein identification, Western blotting and immunohistochemistry. Our results showed that keratin 1 (K1)/K10 together with the new synthesis of K6/K16 were down-regulated and that K5/K14, K2e and involucrin were up-regulated. We found that involucrin was strongly stained in lower epidermal cell layers while K1/10 was weakly stained, particularly when compared with staining in normal epidermis. Additionally, we found that the expression of involucrin was increased. These results imply an aberrant early and terminal differentiation stage in the epidermis of systemic lupus erythematosus, which may be associated with inflammatory cytokines released during the wound healing response of lesion.
Cytokeratins (CK) are major structural proteins specifically expressed in epithelial cells, in which they form intermediate filaments (IF) [1−3] . CK are encoded by a large multigene family, and classified as type I keratin 9 (K9−K20) or type II (K1−K8). Interestingly, keratin are always formed from balanced paired type I and type II keratin polypeptides [4] . In normal human epidermis, the basal keratinocytes proliferate slowly and express CK5 (type II) and CK14 (type I), while the suprabasal keratinocytes related to terminal differentiation express largely CK1 (type II) and CK10 (type I) [5−7] . However, in response to epidermal injury or certain skin disorders, an alternative pattern is open to keratinocytes [8−10] .
Analyzing the distribution and expression of several immunohistochemical markers can help us understand the histogenesis and differentiation of skin disorders better. Among these markers, CK are incredibly useful in identifying the direction of differentiation or growth features [11, 12] . Recently, monoclonal or polyclonal antibodies against certain subtypes of keratin polypeptide became available, and several studies have since been performed on the expression of CK in various skin diseases [13] . Vaidya et al showed that the loss of K5 expression in the oral lining epithelia seemed to play an important role in malignant transformation [14] . In psoriatic epidermis, there were common changes in keratin expression with decreased K1/K10 and increased K6/K16, which suggested hyperproliferation and disturbed differentiation [8] .
There have been few studies about CK expression in patients with systemic lupus erythematosus (SLE). In this study, we used a proteomics approach to clarify the abnormal expression of CK in lesions from SLE patients. We also detected the deposition and distribution of keratins using immunohistochemical techniques. Our results were expected to clarify the abnormal differentiation of epidermal cells, which might lead to a better understanding of the pathogenesis of developing lesions in SLE patients.
Materials and Methods

Patient tissue samples
Samples of skin lesions were collected from 10 patients who fulfilled the criteria for SLE proposed by the American Rheumatism Association [15] . Biopsies were taken from affected, untreated and clinically typical skin, usually from the face, abdomen or extremities. Also, biopsies of normal skin from 10 healthy volunteers with no history or signs of skin disorder were obtained to serve as controls. Both the volunteers and patients were given informed consent prior to enrolling in the study. The type of skin lesion (DLE-like, two cases; SCLE-like, two cases; ACLE-like, six cases) was assessed according to Gilliam's classification [16, 17] . The main portion of each specimen was processed for routine histopathologic examination. The remaining portion was immediately frozen in liquid nitrogen and stored at −80 ºC.
Extraction procedure
The tissue biopsies for two-dimensional gel electrophoresis (2-DE) were washed with phosphate-buffered saline (PBS). The whole epidermis was separated from the dermis with PBS containing 0.25% dispase at 4 ºC for 18 h. Then it was dissolved in a standard cell lysis buffer (pH 8.5) containing 30 mM Tris, 2 M thiourea, 7 M urea, 4% (W/V) CHAPS, and 1% protease inhibitor cocktail (Amersham Biosciences, Uppsala, Sweden), and then centrifuged at 5000 g for 30 min at 4 ºC. The supernatant was then collected and the concentration of total proteins was determined using a 2D Quantification kit (Amersham Biosciences). After that, the concentration was adjusted to 5 mg/ml using the lysis buffer and was deep-frozen in liquid nitrogen and stored at −80 ºC.
Two-dimensional gel electrophoresis
A 500 µg sample was set to 450 µl with rehydration buffer [7 M urea, 2 M thiourea, 4% (W/V) CHAPS, 10% (V/V) isopropanol, 5% (V/V) glycerol, 25 mM dithiothretiol, 0.002% (W/V) bromophenol blue, and 1% (V/V) pH 3−10 NL IPG buffer] and then loaded onto non-linear immobilized pH gradients strips (24 cm, pH 3−10 NL; Amersham Biosciences). Isoelectric focusing was conducted according to the following procedure: 30 V×12 h, 500 V×1 h, 1000 V×1 h, 3000 V×1 h, 5000 V×1 h and 8000 V for 8−12 h until a total of 100,000 Vh. The second dimension was performed in 12.5% sodium dodecylsulfate-polyacrylamide gels stained by Coomassie brilliant blue R-250 and scanned at 300 dpi resolution. Spot detection and quantification were performed with Image Master 2-D software (Amersham Biosciences).
Matrix-assisted laser desorption and ionization-time of flight mass spectrometry (MALDI-TOF MS) and protein identification
The protein spots showing differential expression were cut from the gels, washed, destained, dried and then incubated in digestion solution (40 mM NH 4 HCO 3 in 9% acetonitrile solution, and 20 µg/ml proteomics grade trypsin) for 12 h at 37 ºC . The samples were then analyzed using MALDI-TOF mass spectrometer (Micromass, Manchester, UK). Protein identification was performed by searching the Swiss-Prot or NCBInr database using Mascot (http://www.matrixscience.com) [18] . Database searches were conducted according to following criteria: all entries or homo sapiens, parent ion mass tolerance at 100 ppm, the mass tolerance of 0.5 Da, MS/MS mass tolerance of 0.2 Da, carbamidomethylation of cysteine (fixed modification), and methionine oxidation (variable modification).
Western blotting analysis
Total proteins were extracted from the separated epidermis and separated by electrophoresis in 12% sodium dodecylsulfate-polyacrylamide gel. Then the proteins were transferred to polyvinylidene difluoride membranes incubated with blocking buffer (5% non-fat milk in Trisbuffered saline Tween). The amount of keratin was then detected using anti-cytokeratin 1, 2, 5, 6, 10, 14 and 16, and anti-involucrine antibodies. Antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, USA) and used at the manufacturer's recommended dilutions. In this study, tublin was used as loading control. The results were then visualized using the enhanced chemiluminescence detection system (Santa Cruz, USA). All Western blot analyses were performed at least three times.
Immunohistochemistry
Formalin-fixed and paraffin-embedded tissues were cut into 5 µm sections for immunostaining. Then sections were deparaffinized and dehydrated. After blocking endogenous peroxidase activity, specimens were submitted at 100 ºC with 10 mM sodium citrate buffer solution (pH 6.0) for antigen retrieval [19] . To eliminate non-specific staining, slides were incubated for 20 min with normal non-immune serum. Then, specimens were incubated with primary antibodies, biotin-labeled anti-mouse secondary antibody and peroxidase-labeled streptavidin (Dako, Carpinteria, USA) for 30 min each. Primary antibodies clones, sources and dilutions are described in Table 1 . The slides were then visualized with 3,3′-diaminobenzidine tetrahydrochloride for 5 min. Negative controls were carried by a solution of 1% bovine serum albumin in Tris-HCl (pH 7.4) replaced the primary antibody. An arbitrary scale of positive intensity was used: − (negative); + (1%−33%); ++ (34%−66%); +++ (67%−100%).
Statistical analysis
Statistical analysis was performed using SPSS software (SPSS, Chicago, USA). The densities of 2-DE spots were evaluated by Student's t-test. The difference in immunohistochemical stained between the two groups was determined using the Mann-Whitney U-test. A level of P<0.05 was considered to be statistically significant.
Results
Protein profiling and identification of differentially expressed proteins
To compare cytokeratin profiles between SLE lesions and normal skin, we first performed 2-DE analysis and Coomassie brilliant blue staining (Fig. 1) , and then subjected the samples to Image Master 2-D imaging analysis. The 2-DE for all selected samples from both groups was repeated three times to analyze the repetitiveness of the method. Approximately 1400 spots were obtained from each sample (pH 3-10) in 2-DE maps. After normalization, the spots' densities were determined based on total quantity in the analysis set. Protein spots that showed significant and consistent increased or decreased density (paired t-test, P<0.05) were selected and defined as up-or downregulated spots. According to this definition, we found 16 spots that were up-regulated and nine that were downregulated in SLE lesions (Fig. 1) .
The differential protein spots were excised from the gels, digested with trypsin and then analyzed by MALDI-TOF mass spectrometry in combination with a database search. We identified 18 spots. (No unique peptide masses were observed for the other seven proteins.) All details on the mass spectrometric identification are described in Table 2 . Because keratin is known as a sensitive marker of keratinocyte differentiation, which plays a pivotal role in lesion development, we focused on keratin in more detail in this study. Mascot searches identified involucrin and seven keratins with good peptide coverage and significant scores. Compared with normal samples, K1 and K10 were down-regulated in SLE lesions while K2e, K5, K6, K14, K16 and involucrin in were up-regulated.
Validation of differentially expressed proteins
To confirm the differential expression levels of the cytokeratin and involucrin identified with the comparative proteomics approach, the expressional levels of the proteins were measured by Western blot analysis. The K1/K10, K5/K14, K6/K16 and K2e expression in the two groups was analyzed by Western blotting [ Fig. 2(A) The peptide profiles of the protein spots were analyzed by matrix-assisted laser desorption and ionization-time of flight mass spectrometry using the Mascot program. The percent coverage of analyzed peptides, the mass and isoelectric point (pI) from the database were shown for each protein. Mean, average volume ratio of the altered protein in systemic lupus erythematosus lesion to altered protein in normal skin based on three independent experiments. in SLE lesions, while K1/K10 were down-regulated [ Fig.  2(B) ]. Especially, keratin 6 was only expressed in SLE lesions but not in normal skin. These results were identical to those obtained by 2-DE.
Immunohistochemical observations
The immunohistochemical staining results were similar to those from 2-DE and immunoblot analyses, with some exceptions (Table 3) . In normal epidermis, K1 and K10 were homogeneously expressed throughout the suprabasal compartment. K5 and K14 recognized epitopes specific to the basal cell layer in the epidermis. The upper third of the normal epidermis was stained with anti-involucrin antibody [20] . With respect to K2e, the expression was mostly restricted to the upper suprabasal layers and was weak or absent.
In the epidermis of SLE, a pattern of cytokeratins expression and distribution was shown (Fig. 3) . Suprabasal keratinocytes were stained weakly with LH6 and LH8 (against K1 and K10) compared with the normal controls. On the other hand, K5 and K14 were up-regulated and were not only limited to basal cells but to suprabasal cells as well. K6 and K16 appeared in almost all epithelial layers.
With regard to K2e, all cases had a positive reaction to a variable degree. Concerning anti-involucrin antibody, positive staining was shown in lower epidermal cell layers in contrast to normal.
Discussion
In our study, we presented the first global protein analysis Table 3 Results of immunohistochemical staining K, keratin; SLE, systemic lupus erythematosus. of skin from patients with SLE using proteomic approach (2-DE in combination with MS). This method resulted in the identification of 18 proteins. We were unable to identify any unique peptide mass from the other seven spots most likely due to the sensitivity of the mass spectrometer or ineffective tryptic digestion. These proteins included heat shock 70 kDa protein 2, squamous cell carcinoma antigen (SCCA) 2, annexin II, NT5C3 protein, phospholipase C β1, proteasome subunit α type 7, voltage-dependent anion channel 1, testin, mitochondrial ribosomal protein S9, involucrin and seven keratins. The heat shock proteins (Hsp) are a group of proteins that regulate the folding and unfolding of other protein.
Increased expression of both Hsp90 and Hsp72 had been identified in the peripheral blood mononuclear cells in patients with lupus [21] . In our results, the up-regulation of Hsp70 was also seen in the lesions from SLE patients, which could mean it is involved in the pathogenesis of autoimmunity. SCCA served as a serological marker for more advanced squamous cell tumors [22] . Recently, the ability of SCCA2 to inhibit tumor necrosis factor alphainduced apoptosis in HeLa cells has been reported [23] . The altered SCCA2 expression in our study might be the result of the abnormal proliferation in keratinocytes. It is conceivable that lipid metabolism-related gene disorders could produce the dry skin that leads to scratching and further promotes SLE lesion severity. We detected several lipid metabolism-associated proteins, such as annexin I and phospholipase C β1, differentially regulated in the present study.
Cytokeratin is known as a useful biological marker in epithelial tissue differentiation and as a key protein in keratinocytes activation [24] . The present study mainly focused on the expression and distribution of these sensitive markers in order to get a better understanding of the development of SLE lesions. Although many researchers have used highly concentrated salts and detergents to prepare keratin [25] , this same treatment of cultured cells might be too harsh for cytokeratin preparation. Certain unstable cytokeratins might become lost in the process. In our study, we successfully analyzed the cytokeratins from the total protein of keratinocytes using 2-DE systems.
Previous studies had shown that the expressions of K1/K10 were disturbed in psoriatic epidermis, SCC and Bowen's disease [26] . de Berker et al showed that reduction of suprabasal Kl expression was seen in 59% (10/17) of lesions from patients with discoid lupus erythematosus [27] , while another study indicated that there was no significant difference in expression of K1/K10 [20] . Nevertheless, our study showed that K1/K10 were down-regulated in SLE lesions in contrast to the normal epidermis. These keratins were the specific markers for early differentiated keratinocytes, which implied an aberrant early differentiation stage in the epidermis of SLE. Meanwhile, our study also showed that the expression of involucrin, a marker for terminal keratinization [20] , was increased and strongly stained in the lower epidermal. We thought the pattern could be explained by wound healing response. In the course of the recovery, keratinocytes were in the state of hyperproliferative and had to finish keratinization in much shorter time, which led to an earlier-thanusual expression of involucrin [28] .
As markers of hyperproliferative or activated keratinocytes, K6/K16 were present in hyperproliferative skin disease, but they were not present in normal epidermis in a previous study [29] . We found this staining pattern was also seen in non-hyperproliferative and atrophic epidermis in SLE lesions. It has been reported that epidermal growth factor and transforming growth factor alpha at the transcriptional level induce the expression of these keratins [30] , which were enriched during the phase of wound healing. These inflammatory cytokines might change the expression of K5/K14 as well [31] . In normal epithelia, K5/K14 were limited to basal cells. In the present work, the expression of K5/K14 broadened, and they appeared in all layers of the epithelium analyzed.
By cloning the complementary DNA for K2, Collin et al identified this protein in 1992 [7] . Consistent with previous studies [32] , this present work showed that K2e was upregulated in SLE lesions. Despite mutations in the K2e gene related to a mild disruption in the epidermis known as ichthyosis bullosa of Siemens [33] , no definite function for this keratin protein had been documented. Bloor's work showed that K2e was sensitive to keratinocyte activation. The most activated keratinocytes did not express K2e whereas mildly or moderately activated ones did [32] . The up-regulation of K2e in our study suggests that the status of keratinocytes activation was low grade rather than marked in SLE lesions.
In conclusion, using a proteomic approach, we have successfully found for the first time differentially expressed proteins in lesions from SLE patients. Our study further showed that keratins, the key protein in keratinocyte activation, proliferation and keratinization, presented an alterative pattern in expression and distribution. This implied an aberrant early and terminal differentiation stage in the epidermis of SLE. The alterative pattern, which may be associated with wound healing response, was reminiscent of epidermal hyperproliferation. However, the molecular mechanisms still required further study and must be
